284 related articles for article (PubMed ID: 1506634)
1. Liver damage from flucloxacillin, cloxacillin and dicloxacillin.
Olsson R; Wiholm BE; Sand C; Zettergren L; Hultcrantz R; Myrhed M
J Hepatol; 1992 May; 15(1-2):154-61. PubMed ID: 1506634
[TBL] [Abstract][Full Text] [Related]
2. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?
Devereaux BM; Crawford DH; Purcell P; Powell LW; Roeser HP
Eur J Clin Pharmacol; 1995; 49(1-2):81-5. PubMed ID: 8751026
[TBL] [Abstract][Full Text] [Related]
3. [Endothelial damage caused by the semisynthetic penicillins cloxacillin dicloxacillin and flucloxacillin].
Sinapius D; Bründel KH
Vasa; 1975; 4(1):54-8. PubMed ID: 1189592
[No Abstract] [Full Text] [Related]
4. Flucloxacillin induced delayed cholestatic hepatitis.
Miros M; Kerlin P; Walker N; Harris O
Aust N Z J Med; 1990 Jun; 20(3):251-3. PubMed ID: 2372276
[TBL] [Abstract][Full Text] [Related]
5. Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story.
Boyd IW
Med J Aust; 1999 Aug; 171(4):219. PubMed ID: 10494242
[No Abstract] [Full Text] [Related]
6. Flucloxacillin and cholestatic hepatitis.
Jick H; Derby LE; Dean AD; Henry DA
Med J Aust; 1994 Apr; 160(8):525. PubMed ID: 8170433
[No Abstract] [Full Text] [Related]
7. Toxicities of flucloxacillin and dicloxacillin--is there really a difference?
Gosbell IB; Turnidge JD; Tapsall JW; Benn RA
Med J Aust; 2000 Nov; 173(9):500-1. PubMed ID: 11149309
[No Abstract] [Full Text] [Related]
8. [Risk of liver reactions after treatment with flucloxacillin].
Lakartidningen; 1989 Mar; 86(11):977-8. PubMed ID: 2927200
[No Abstract] [Full Text] [Related]
9. Relationship between penicillinase production and the in-vitro activity of methicillin, oxacillin, cloxacillin, dicloxacillin, flucloxacillin, and cephalothin against strains of Staphylococcus aureus of different phage patterns and penicillinase activity.
Frimodt-Møller N; Rosdahl VT; Sørensen G; Hartzen SH; Bentzon MW
J Antimicrob Chemother; 1986 Jul; 18(1):27-33. PubMed ID: 3489704
[TBL] [Abstract][Full Text] [Related]
10. Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database.
Russmann S; Kaye JA; Jick SS; Jick H
Br J Clin Pharmacol; 2005 Jul; 60(1):76-82. PubMed ID: 15963097
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.
Rodriguez-Solares A; Pérez-Gutiérrez F; Prosperi J; Milgram E; Martin A
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():103-9. PubMed ID: 8396081
[TBL] [Abstract][Full Text] [Related]
12. Flucloxacillin-induced cholestatic liver damage.
Bengtsson F; Florén CH; Hägerstrand I; Söderström C; Aberg T
Scand J Infect Dis; 1985; 17(1):125-8. PubMed ID: 3992199
[TBL] [Abstract][Full Text] [Related]
13. Flucloxacillin-associated hepatic injury.
Koek GH; Stricker BH; Blok AP; Schalm SW; Desmet VJ
Liver; 1994 Oct; 14(5):225-9. PubMed ID: 7997079
[TBL] [Abstract][Full Text] [Related]
14. Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin.
Sutherland R; Croydon EA; Rolinson GN
Br Med J; 1970 Nov; 4(5733):455-60. PubMed ID: 5481218
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of cloxacillin, dicloxacillin and flucloxacillin in dental alveolar serum and mandibular bone.
Köndell PA; Nord CE; Nordenram A
Int J Oral Surg; 1982 Feb; 11(1):40-3. PubMed ID: 6811456
[TBL] [Abstract][Full Text] [Related]
16. Cholestatic hepatitis associated with flucloxacillin.
Derby LE; Jick H; Henry DA; Dean AD
Med J Aust; 1993 May; 158(9):596-600. PubMed ID: 8479374
[TBL] [Abstract][Full Text] [Related]
17. Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story.
McNeil JJ; Grabsch EA; McDonald MM
Med J Aust; 1999 Mar; 170(6):270-3. PubMed ID: 10212650
[TBL] [Abstract][Full Text] [Related]
18. Dicloxacillin: a higher risk than cloxacillin for infusion phlebitis.
Lanbeck P; Odenholt I; Paulsen O
Scand J Infect Dis; 2003; 35(6-7):397-400. PubMed ID: 12953952
[TBL] [Abstract][Full Text] [Related]
19. Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study.
Wing K; Bhaskaran K; Pealing L; Root A; Smeeth L; van Staa TP; Klungel OH; Reynolds RF; Douglas I
J Antimicrob Chemother; 2017 Sep; 72(9):2636-2646. PubMed ID: 28859440
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury.
Monshi MM; Faulkner L; Gibson A; Jenkins RE; Farrell J; Earnshaw CJ; Alfirevic A; Cederbrant K; Daly AK; French N; Pirmohamed M; Park BK; Naisbitt DJ
Hepatology; 2013 Feb; 57(2):727-39. PubMed ID: 22987284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
